Literature DB >> 1858981

Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy.

R F Barth1, D M Adams, A H Soloway, E B Mechetner, F Alam, A K Anisuzzaman.   

Abstract

We have developed a safe, simple, and efficient method for boron determination by means of direct-current plasma atomic emission spectroscopy. Tissues were solubilized by using concentrated sulfuric acid and 70% hydrogen peroxide to digest the samples without the need of high temperatures and pressures. Boron cluster compounds could be measured with sensitivity, precision, and accuracy similar to those of boric acid standards. Results obtained with [(C2H5)3NH]2B12H12, Cs2B12H11SH.H2O, and C15H32B10O6 show that this analytical method is applicable to a variety of compounds with different chemical structures. A sensitivity of 0.1 ppm has been obtained with known standards alone and in a variety of tissue matrices including tumor, blood, liver, skin, and cell suspensions. The measurement of total boron by direct-current plasma atomic emission spectroscopy (DCP-AES) has been achieved with as little as 50 mg of tissue or as few as 5 x 10(7) cells. The procedure is applicable to the analysis of boron in the ppm range with a high degree of precision and accuracy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1858981     DOI: 10.1021/ac00009a010

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  17 in total

1.  Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine.

Authors:  J A Coderre; P R Gavin; J Capala; R Ma; G M Morris; T M Button; T Aziz; N S Peress
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors.

Authors:  N Gupta; R A Gahbauer; T E Blue; B Albertson
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

3.  Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Authors:  W Yang; R F Barth; J H Rotaru; C P Boesel; D A Wilkie; J C Bresnahan; M Hadjiconstantinou; V M Goettl; D D Joel; M M Nawrocky
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

4.  Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery.

Authors:  Chenguang Zhou; Bo Yu; Xiaojuan Yang; Tianyao Huo; L James Lee; Rolf F Barth; Robert J Lee
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

5.  Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.

Authors:  D D Joel; J A Coderre; P L Micca; M M Nawrocky
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

6.  Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.

Authors:  Jennifer J Sudimack; Dianne Adams; Joan Rotaru; Supriya Shukla; Junhua Yan; Masaru Sekido; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

7.  Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Authors:  W Yang; R F Barth; J H Rotaru; M L Moeschberger; D D Joel; M M Nawrocky; J H Goodman
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

8.  Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.

Authors:  Rolf F Barth; Weilian Yang; Gong Wu; Michele Swindall; Youngjoo Byun; Sureshbabu Narayanasamy; Werner Tjarks; Kevin Tordoff; Melvin L Moeschberger; Staffan Eriksson; Peter J Binns; Kent J Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

Review 9.  A critical assessment of boron target compounds for boron neutron capture therapy.

Authors:  M Frederick Hawthorne; Mark W Lee
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

10.  Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.

Authors:  Christopher R Gibson; Alfred E Staubus; Rolf F Barth; Weilian Yang; Amy K Ferketich; Melvin M Moeschberger
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.